HPV Vaccine in East Melbourne
Specialist GP consult is bulk-billed for Medicare card holders, $149 without. For adults 26 to 45, the vaccine itself is paid separately at the consult — it is not NIP-funded for this age group. For people aged 9 to 25, the vaccine is free under the National Immunisation Program (single-dose schedule).
HPV vaccination is most effective before first sexual exposure, but provides meaningful protection at any age up to 45. It reduces the chance of new HPV-type infections, with secondary benefit on cervical cancer rates and reduced
genital wart recurrence after treatment. It does not clear existing HPV infection.
What HPV is. HPV is a common virus — around 80% of sexually active adults are exposed at some point. Most people clear the infection without issues. A smaller number develop genital warts or persistent infection with high-risk strains. Persistent high-risk infection is the cause of nearly all cervical cancers and is also linked to anal, oropharyngeal, vulvar, vaginal, and penile cancers. There is no treatment that clears the virus itself — the focus is on prevention through vaccination and on screening for and treating any changes the virus causes.
Who the vaccine protects. Adolescents and young adults via the school-based program from age 12 with catch-up to 25; adults catching up between 26 and 45 who were not vaccinated growing up; men who have sex with men of any age; people with immune-compromising conditions; and anyone with new partners or ongoing exposure who has not completed a schedule. The vaccine has its strongest effect before first exposure but provides meaningful benefit for sexually active people too.
How the vaccine works. Gardasil 9 is made from virus-like particles that contain no infectious material. The vaccine covers nine HPV strains, including the strains responsible for around 90% of cervical cancers and the strains that cause most genital warts. Protection has been demonstrated out to 14 years with no evidence yet of waning immunity.
Schedule for people aged 9 to 25 (single dose, NIP-funded). A single dose is now standard for people aged 9 to 25 under the Australian National Immunisation Program. The vaccine is offered through the school-based program at year 7. Anyone who missed their school dose, or who completed schooling without being offered the vaccine, can still receive a single catch-up dose through a GP up to age 25. The single-dose schedule is supported by strong evidence of equivalent protection to the older multi-dose schedules.
Schedule for adults 26 to 45 (three doses, paid). Three doses are recommended for adults catching up between 26 and 45, given at 0, 2, and 6 months. Three doses are needed in this age group because most adults have likely had some prior exposure and a stronger immune response is required to establish broad protection. The vaccine is paid separately at the consult — this age group is outside the NIP-funded pathway. The first dose is usually given at the consult; follow-up doses are scheduled at the appropriate interval. Vaccine cost is quoted on the day.
Schedule for immune-compromised patients. People living with HIV, organ transplant recipients, those on certain cancer treatments, and people with primary immune deficiencies need three doses regardless of age. The Specialist GP confirms the right schedule and timing at the consult.
What happens at the consult. The Specialist GP takes a focused history (previous vaccination record, any prior HPV-related issues, allergies), confirms the right schedule, gives the first dose where appropriate, and records the vaccination on the Australian Immunisation Register (AIR). Other vaccines due at the same time (Hep A/B, Mpox, MMR catch-up, flu) can usually be given in the same visit.
Side effects and safety. The most common side effect is a sore arm at the injection site, sometimes with a small red area, for a day or so. Some people get a headache, mild fever, or feel tired for 24 hours. Rare allergic reactions are managed on site. The HPV vaccine has been given to more than 100 million people globally with an excellent safety record. Vaccination is generally deferred during pregnancy out of caution; breastfeeding is not a reason to defer.
Vaccination does not replace cervical screening. The vaccine covers most but not all cancer-causing HPV strains, so a small risk of cervical cancer remains even in fully vaccinated people. Cervical screening every five years from age 25 is recommended for everyone with a cervix, regardless of vaccination status.